What is Cramer?
Cramer specializes in engineering high-quality, lab-grade seating solutions designed for sensitive Med-Tech environments such as laboratories, medical offices, hospitals, and research facilities. Their product line, including the Citrus seating solution and the Rhino series, emphasizes a blend of modern design, intuitive functionality, and durability. The chairs and stools feature molded polyurethane for resistance to chemical and physical damage, ensuring ease of cleaning and all-day support. Cramer's patented Rhino Plus Technology further enhances their offerings for Med-Tech applications, meeting rigorous technical standards while prioritizing user comfort and performance.
How much funding has Cramer raised?
Cramer has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cramer
PPP
Public-Private Partnership
What's next for Cramer?
With its recent large-scale, late-stage funding, Cramer is poised for significant expansion and further innovation in the Med-Tech seating sector. This strategic investment will likely fuel advancements in product development, potentially broadening their market reach and enhancing manufacturing capabilities. The company's focus on specialized, high-performance seating solutions positions it to capitalize on the growing demand for compliant and ergonomic furniture in healthcare and research environments. Future growth may involve expanding their product lines, entering new geographical markets, and solidifying partnerships within the broader Med-Tech ecosystem.
See full Cramer company page
